Overall rank by patents
#29,888
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Rocin Laboratories, Inc
USPTO PatentsView assignee record - 9 granted patents across 2 technology areas, active 2017–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
9
Total patents granted
2
CPC technology areas
11.2
Avg claims per patent
-50%
5-year filing velocity
The verdict
Rocin holds 9 US patents across 2 technology areas, rank #29,888 of 50,000 tracked assignees.
- #29,888
- of 50,000 US assignees by volume
- Top 37%
- by Innovation Score (39.7/100)
- 11.2
- avg claims per patent
- -50%
- filing velocity, last 5 yrs
Portfolio overview
Rocin Laboratories, Inc has been granted 9 US utility patents between 2017 and 2024, placing Rocin Laboratories, Inc at rank #29,888 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.2 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Rocin Laboratories, Inc is one of the more focused assignees in the PatentsView dataset. By volume, Rocin sits between RF Printing Technologies (9 patents, rank #29,884) and Ronchi Mario S.p.a. (9 patents, rank #29,892) - the closest US assignees by grant volume. The composite Innovation Score of 39.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 6 in the 2015–2019 window, a -50% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Rocin Laboratories, Inc's 11.2 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Rocin Laboratories, Inc against peers pursuing similar technology classes.
Who files at Rocin's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- RF Printing
RF PRINTING TECHNOLOGIES
9 patents
- Ripple+
RIPPLE+ LIMITED
9 patents
- RM2 Technology
RM2 TECHNOLOGY LLC
9 patents
- ROAL OY
ROAL OY
9 patents
- Rocky Brands
ROCKY BRANDS, INC.
9 patents
- Rollomatic
ROLLOMATIC S.A
9 patents
- Rolls-royce Contr…
ROLLS-ROYCE CONTROLS AND DATA SERVICES LIMITED
9 patents
- Ronchi Mario S P A
RONCHI MARIO S.P.A.
9 patents
- Rocin Laboratories ◀
ROCIN LABORATORIES, INC
9 patents
What this shows Rocin holds 9 patents at rank #29,888, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Rocin
By rank, the assignees closest to #29,888 in granted patent volume.
- RF Printing Technologies #29,884 · 9 patents
- Ripple+ Limited #29,885 · 9 patents
- RM2 Technology Llc #29,886 · 9 patents
- ROAL OY #29,887 · 9 patents
- Rocky Brands, Inc. #29,889 · 9 patents
- Rollomatic S.a #29,890 · 9 patents
- Rolls-royce Controls AND DATA Services Limited #29,891 · 9 patents
- Ronchi Mario S.p.a. #29,892 · 9 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Rocin's primary technology class.
- Covidien Lp 5,709 in class
- Koniniklijke Philips N.v. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag Gmbh International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- Depuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Rocin's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
40 Top 37% higher than 63% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 5 | 55.6% |
| 2018 | 1 | 11.1% |
| 2022 | 1 | 11.1% |
| 2024 | 2 | 22.2% |
Which technologies does Rocin Laboratories, Inc patent most?
Top 2 of 2 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Simple
Velocity Declining
Frequently Asked Questions
How many patents does Rocin Laboratories, Inc hold?
Rocin Laboratories, Inc holds 9 US granted patents filed between 2017 and 2024, spanning 2 technology areas.
What is Rocin Laboratories, Inc's Innovation Score?
Rocin Laboratories, Inc has an Innovation Score of 39.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Rocin Laboratories, Inc focus on?
Rocin Laboratories, Inc's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 9 patents. The company has filed patents in 2 CPC subclasses total.
Is Rocin Laboratories, Inc's patent filing rate increasing or decreasing?
Rocin Laboratories, Inc's recent filing velocity is -50% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Rocin Laboratories, Inc's patents?
Rocin Laboratories, Inc's patents average 11.2 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Rocin Laboratories, Inc patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Rocin's 9 grants land it in the top 37% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Rocin ranks #29,888 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.